Latest filings (excl ownership)
8-K
Other Events
23 Sep 24
S-8
Registration of securities for employees
8 Aug 24
10-Q
2024 Q2
Quarterly report
8 Aug 24
8-K
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
8 Aug 24
8-K
Assembly Biosciences Announces $12.6 Million in Equity Financings
18 Jun 24
424B5
Prospectus supplement for primary offering
18 Jun 24
8-K
Departure of Directors or Certain Officers
3 Jun 24
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
8 May 24
DEFA14A
Additional proxy soliciting materials
17 Apr 24
DEF 14A
Definitive proxy
17 Apr 24
ARS
2023 FY
Annual report to shareholders
17 Apr 24
8-K
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
28 Mar 24
8-K
Departure of Directors or Certain Officers
15 Mar 24
8-K
Assembly Biosciences Announces Effective Date of Reverse Stock Split
13 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
2 Feb 24
8-K
Termination of a Material Definitive Agreement
17 Jan 24
DEFA14A
Additional proxy soliciting materials
21 Dec 23
DEF 14A
Definitive proxy
21 Dec 23
PRE 14A
Preliminary proxy
11 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
8 Nov 23
8-K
Entry into a Material Definitive Agreement
17 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Sep 23
S-8
Registration of securities for employees
9 Aug 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates
9 Aug 23
8-K
Entry into a Material Definitive Agreement
7 Aug 23
8-K
Departure of Directors or Certain Officers
30 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Assembly Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights
4 May 23
8-K
Other Events
18 Apr 23
EFFECT
Notice of effectiveness
17 Apr 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
ARS
2022 FY
Annual report to shareholders
12 Apr 23
CORRESP
Correspondence with SEC
12 Apr 23
PRE 14A
Preliminary proxy
31 Mar 23
UPLOAD
Letter from SEC
24 Mar 23
Latest ownership filings
4
Alexander Schornstein
9 Oct 24
4
Nicole S White
4 Oct 24
4
Jason A Okazaki
4 Oct 24
4
Nicole S White
5 Aug 24
4
Jason A Okazaki
5 Aug 24
4
Alexander Schornstein
8 Jul 24
SC 13D/A
Schornstein Alexander
24 Jun 24
SC 13D/A
GILEAD SCIENCES, INC.
20 Jun 24
4
Change in insider ownership
20 Jun 24
4
Lisa Johnson-Pratt
30 May 24
4
John G McHutchison
30 May 24
4
Susan Mahony
30 May 24
4
Michael Houghton
30 May 24
4
Gina Consylman
30 May 24
4
ANTHONY E ALTIG
30 May 24
4
WILLIAM R RINGO
30 May 24
4
Jeanette M Bjorkquist
24 May 24
4
John G McHutchison
24 May 24
4
Nicole S White
24 May 24
4
Jason A Okazaki
24 May 24
4
Nicole S White
1 May 24
4
Jason A Okazaki
1 May 24
4
William E IV Delaney
1 May 24
4
John G McHutchison
2 Apr 24
4
Jeanette M Bjorkquist
2 Apr 24
4
Nicole S White
2 Apr 24
4
William E IV Delaney
2 Apr 24
4
Jason A Okazaki
2 Apr 24
4
Jason A Okazaki
29 Mar 24
3
Robert Donald Cook II
15 Mar 24
4
Alexander Schornstein
19 Jan 24
3
Tomas Cihlar
11 Dec 23
SC 13D/A
Schornstein Alexander
22 Nov 23
4
Alexander Schornstein
22 Nov 23
4
Nicole S White
21 Nov 23
4
Anuj Gaggar
13 Nov 23
3
Anuj Gaggar
13 Nov 23
SC 13D/A
Schornstein Alexander
3 Nov 23
SC 13D
Schornstein Alexander
31 Oct 23
3
Alexander Schornstein
31 Oct 23